Perspectives on Model-Informed Precision Dosing in the Digital Health Era: Challenges, Opportunities, and Recommendations
Clin Pharmacol Ther
.
2021 Jan;109(1):29-36.
doi: 10.1002/cpt.2049.
Epub 2020 Oct 17.
Authors
Franziska Kluwe
1
2
,
Robin Michelet
1
,
Anna Mueller-Schoell
1
2
,
Corinna Maier
2
3
,
Lena Klopp-Schulze
1
2
,
Madelé van Dyk
4
,
Gerd Mikus
1
5
,
Wilhelm Huisinga
3
,
Charlotte Kloft
1
Affiliations
1
Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
2
Graduate Research Training Program PharMetrX, Freie Universität Berlin and Universitaet Potsdam, Berlin, Germany.
3
Institute of Mathematics, Universität Potsdam, Potsdam, Germany.
4
Flinders Centre for Innovation in Cancer, College of Medicine & Public Health, Flinders University, Adelaide, Australia.
5
Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital Heidelberg, Heidelberg, Germany.
PMID:
33068303
DOI:
10.1002/cpt.2049
No abstract available
MeSH terms
Dose-Response Relationship, Drug
Humans
Pharmaceutical Preparations / administration & dosage*
Precision Medicine / methods*
Substances
Pharmaceutical Preparations